Research and Development, Pharmaceuticals, Bayer AG, 13353, Berlin, Germany.
Angew Chem Int Ed Engl. 2020 Sep 1;59(36):15448-15466. doi: 10.1002/anie.202004310. Epub 2020 Jul 30.
Targeted protein degradation (TPD), the ability to control a proteins fate by triggering its degradation in a highly selective and effective manner, has created tremendous excitement in chemical biology and drug discovery within the past decades. The TPD field is spearheaded by small molecule induced protein degradation with molecular glues and proteolysis targeting chimeras (PROTACs) paving the way to expand the druggable space and to create a new paradigm in drug discovery. However, besides the therapeutic angle of TPD a plethora of novel techniques to modulate and control protein levels have been developed. This enables chemical biologists to better understand protein function and to discover and verify new therapeutic targets. This Review gives a comprehensive overview of chemical biology techniques inducing TPD. It explains the strengths and weaknesses of these methods in the context of drug discovery and discusses their future potential from a medicinal chemist's perspective.
靶向蛋白降解(TPD)是一种通过高度选择性和有效的方式触发蛋白质降解来控制蛋白质命运的能力,在过去几十年中在化学生物学和药物发现领域引起了巨大的兴奋。TPD 领域由小分子诱导的蛋白质降解引领,分子胶和 PROTACs 为拓展可成药性空间和开创药物发现的新模式铺平了道路。然而,除了 TPD 的治疗角度外,还开发了许多新的技术来调节和控制蛋白质水平。这使化学生物学家能够更好地理解蛋白质的功能,并发现和验证新的治疗靶点。这篇综述全面概述了诱导 TPD 的化学生物学技术。它解释了这些方法在药物发现中的优缺点,并从药物化学家的角度讨论了它们未来的潜力。